Fludarabine, Campath, TBI T-Cell Deplete NMSCT With Post-Transplant T-Cell Infusions for CML Failing Imatinib Therapy With Imatinib (STI571).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Fludarabine
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 27 Sep 2017 Biomarkers information updated
- 01 Aug 2011 Planned end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.